StockNews.AI
ASRT
StockNews.AI
92 days

Assertio to Participate in the Alliance Global Partners Healthcare Company Showcase on May 21, 2025

1. Assertio will present at the Alliance Global Partners event on May 21. 2. CEO Brendan O’Grady will participate in a live fireside chat. 3. Assertio focuses on oncology, neurology, and pain management products.

3m saved
Insight
Article

FAQ

Why Bullish?

This presentation can attract investor interest, potentially boosting stock prices; similar events for other pharma stocks have shown positive trends.

How important is it?

The presentation showcases Assertio's initiatives, which may enhance market perception and draw investors.

Why Short Term?

The upcoming showcase could lead to immediate investor engagement and interest.

Related Companies

PFEAMGNJNJ
LAKE FOREST, Ill., May 19, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that Brendan O’Grady, Chief Executive Officer, will present at the virtual Alliance Global Partners Healthcare Company Showcase, taking place Wednesday, May 21, 2025. Mr. O’Grady’s fireside chat will be webcast live at 11:20 a.m. ET. To join the event, please register at https://us02web.zoom.us/webinar/register/WN_jB1HgKLvQFmUfC6VBT11mw#/registration, or visit the Events & Presentations page at the Company’s investor relations website, https://investor.assertiotx.com/. About Assertio Assertio is a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs. Our focus is on supporting patients by marketing products in oncology, neurology, and pain management. To learn more about Assertio, visit www.assertiotx.com. Investor Contact Matt Kreps, Managing DirectorDarrow AssociatesM: 214-597-8200mkreps@darrowir.com

Related News